Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Conditions
C3G
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Childrens Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Bradley Dixon)Nicklaus Childrens Hospital, Miami, Florida, United States
Contact: Principal Investigator (Ana Paredes)Georgia Nephrology Research Inst, Lawrenceville, Georgia, United States
IN University School of Med, Indianapolis, Indiana, United States
University of Iowa Health Care, Iowa City, Iowa, United States
Contact: Principal Investigator (Carla Nester)University of Iowa Health Care, Iowa City, Iowa, United States
Contact: Principal Investigator (Carla Nester)Johns Hopkins Hospital, Baltimore, Maryland, United States
Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts, United States
Hackensack Uni Medical Center, Hackensack, New Jersey, United States
Albany Medical Center, Albany, New York, United States
Col Uni Med Center New York Presby, New York, New York, United States
Baylor Scott and White Research, Temple, Texas, United States
University of Wisconsin, Madison, Wisconsin, United States
Contact: Principal Investigator (Sharon Bartosh)Novartis Investigative Site, Córdoba, Córdoba Province, Argentina
Novartis Investigative Site, Buenos Aires, Argentina
Novartis Investigative Site, CABA, Argentina
Novartis Investigative Site, Edegem, Belgium
Novartis Investigative Site, Leuven, Belgium
Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site, Recife, Pernambuco, Brazil
Novartis Investigative Site, Passo Fundo, Rio Grande do Sul, Brazil
Novartis Investigative Site, Joinville, Santa Catarina, Brazil
Novartis Investigative Site, Santo André, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Salvador, Brazil
Novartis Investigative Site, London, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Prague, Czechia
Novartis Investigative Site, Lille, France
Novartis Investigative Site, Marseille, France
Novartis Investigative Site, Montpellier, France
Novartis Investigative Site, Paris, France
Novartis Investigative Site, Paris, France
Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site, Aachen, Germany
Novartis Investigative Site, Erlangen, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Hanover, Germany
Novartis Investigative Site, Heidelberg, Germany
Novartis Investigative Site, Mainz, Germany
Novartis Investigative Site, Athens, Greece
Novartis Investigative Site, Heraklion Crete., Greece
Novartis Investigative Site, Thessaloniki, Greece
Novartis Investigative Site, Thessaloniki, Greece
Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site, Hyderabad, Telangana, India
Novartis Investigative Site, Lucknow, Uttar Pradesh, India
Novartis Investigative Site, Dehradun, Uttarakhand, India
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Ranica, BG, Italy
Novartis Investigative Site, Milan, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Nagoya, Aichi-ken, Japan
Novartis Investigative Site, Asahikawa, Hokkaido, Japan
Novartis Investigative Site, Sapporo, Hokkaido, Japan
Novartis Investigative Site, Takatsuki, Osaka, Japan
Novartis Investigative Site, Ohtsu, Shiga, Japan
Novartis Investigative Site, Niigata, Japan
Novartis Investigative Site, Nijmegen, Gelderland, Netherlands
Novartis Investigative Site, Leiden, South Holland, Netherlands
Novartis Investigative Site, Barcelona, Catalonia, Spain
Novartis Investigative Site, Port de Sagunt, Valencia, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Málaga, Spain
Novartis Investigative Site, Seville, Spain
Novartis Investigative Site, Bern, Switzerland
Novartis Investigative Site, Lausanne, Switzerland
Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site, Kayseri, Melikgazi, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Glasgow, Scotland, United Kingdom
Novartis Investigative Site, Newcastle upon Tyne, Tyne and Wear, United Kingdom
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, London, United Kingdom
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals